Search Results
Sep 10, 2026, 22:51 ET El tercer Foro GTI sobre Inteligencia Digital impulsa el desarrollo global inclusivo de la IA
Seguridad; junto con GTI y la Universidad Politécnica de Hong Kong, lanzó oficialmente la Estación de Trabajo Científica AI4S • Edición Internacional (TG Science); y, junto con GTI y más de 10 socios de la industria, la universidad y la investigación, publicó conjuntamente el informe sobre los logros
More news about: GTI
Sep 10, 2026, 22:50 ET Le 3ᵉ Forum GTI sur l'intelligence numérique - Hong Kong fait progresser le développement mondial et inclusif de l'IA
avec GTI et l'Université polytechnique de Hong Kong, elle a officiellement lancé la station de travail scientifique AI4S • Édition internationale (TG Science) ; et, en collaboration avec GTI et plus de 10 partenaires issus des secteurs de l'industrie, de l'enseignement supérieur et de la recherche,
More news about: GTI
Sep 10, 2026, 07:21 ET The 3rd GTI Forum on Digital Intelligence, Hong Kong Advances Global Inclusive AI Development
Capability System; together with GTI and The Hong Kong Polytechnic University, officially launched the AI4S Scientific Workstation • International Edition (TG Science); and, together with GTI, and over 10 industry-university-research partners, jointly released the Achievement of the 6G Open Testbed:
More news about: GTI
Sep 06, 2026, 20:30 ET 私隱專員公署與HKIRC 攜手推出「數據私隱及網站安全掃描計劃」 防範個人資料外洩風險
及早識別網站潛在風險，加強網絡安全及個人資料保障能力，共同提升香港數碼生態的安全水平及韌性。」計劃即日起接受申請，截止日期為2026年11月16日（星期一）。有興趣的學校、非牟利機構及中小企可透過專設申請渠道提交申請：https://forms.cloud.microsoft/r/UkitjQw6Tg如有任何問題，可透過電郵聯絡：
More news about: 香港互聯網註冊管理有限公司
Sep 03, 2026, 10:00 ET Pillar Biosciences Appoints Todd Christian and Yann Echelard, Ph.D., to Its Board of Directors
Flagship, Dr, Echelard was President and CEO of rEVO Biologics (successor company of Genzyme Transgenics). Dr. Echelard currently serves as a director of TG Therapeutics and as an advisor to the Gene and Cell Therapy Institute (GCTI) of Mass General Brigham Dr. Echelard received his Ph.D. from Université
More news about: Pillar Biosciences, Inc.
Sep 01, 2026, 11:44 ET Tokenized Gold Finds a New Home in Arch Lending's Collateral Book
Paxos Trust Company, represents one fine troy ounce of gold from an LBMA-accredited London Good Delivery bar held in Brink's vaults. XAUT, issued by TG Commodities Limited, represents one fine troy ounce from a London Good Delivery bar held in Swiss custody. Together they account for the overwhelming
More news about: Arch Lending
Aug 26, 2026, 10:41 ET Oncolytic Virus Cancer Therapy Market Expected to Expand Rapidly During the Forecast Period (2026-2036) Amid Rising Investments in Next-Generation Cancer Treatments| DelveInsight
therapies in clinical trials include Cretostimogene grenadenorepvec, CAN-2409, AdAPT-001, LOAd703, RP1, RP2, VG 161, BS001, Olvi-Vec, CF33, BT-001, TG6050, Pelareorep, and others.Discover real-time oncolytic virus analysis @
More news about: DelveInsight Business Research, LLP
Aug 16, 2026, 20:30 ET 私隱專員公署與HKIRC簽署諒解備忘錄並攜手推出「數據私隱及網站安全掃描計劃」防範個人資料外洩風險
及早識別網站潛在風險，加強網絡安全及個人資料保障能力，共同提升香港數碼生態的安全水平及韌性。」計劃即日起接受申請，截止日期為2026年11月16日（星期一）。有興趣的學校、非牟利機構及中小企可透過專設申請渠道提交申請：https://forms.cloud.microsoft/r/UkitjQw6Tg如有任何問題，可透過電郵聯絡：
More news about: 香港互聯網註冊管理有限公司
Aug 11, 2026, 13:45 ET Havis Expands Keyboard Portfolio Through Strategic Partnership with TG3 Electronics
Havis selected TG3 based on three core strengths:Proven performance in demanding environmentsCustom engineering expertiseAbility to accelerate product development and time to market "Expanding our keyboard portfolio with TG3 was a natural choice,"
More news about: Havis, Inc.
Aug 02, 2026, 23:13 ET UD info präsentiert Komplettlösungen für industrietaugliche SD- und microSD-Karten
https://youtu.be/LyyP5d480TgInformationen zu UD infoUD info ist ein in Taiwan ansässiger Hersteller von Speicherlösungen in Industriequalität,
More news about: UD info
Aug 02, 2026, 22:00 ET UD info Launches One-Stop Industrial-Grade SD and microSD Card Solutions
https://youtu.be/LyyP5d480TgAbout UD infoUD info is a Taiwan-based manufacturer of industrial-grade storage solutions, including SSDs, SD and
More news about: UD info
Aug 02, 2026, 22:00 ET UD info lance des solutions tout en un de cartes SD et microSD de qualité industrielle
https://youtu.be/LyyP5d480TgÀ propos de UD infoUD info est un fabricant taïwanais de solutions de stockage de qualité industrielle : disques SSD,
More news about: UD info
Jul 21, 2026, 17:20 ET Kuehn Law Encourages Investors of TG Therapeutics, Inc. to Contact Law Firm
21, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of TG Therapeutics, Inc. (NASDAQ: TGTX) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders
More news about: Kuehn Law, PLLC
Jul 21, 2026, 11:00 ET Electra to Usher in the Next Era of Aviation with Advanced Production Facility in Springfield, Ohio
agreement to develop and produce the TG600 turbogenerator that will power the EL9 Ultra Short. The agreement includes an initial order for 250 units and establishes Safran's TG600 as the core of the EL9's hybrid-electric propulsion system.Earlier this
More news about: Electra.aero
Jul 20, 2026, 10:31 ET Degenerative Disc Disease Market to Observe Stupendous Growth at ~19% CAGR by 2036, Due to Launch of Novel Drug Classes Such as Cell Replacement, NF-kappa B Inhibitors, Cartilage Regeneration via TGF-β1 Expression, and Others | DelveInsight
therapies in clinical trials include SB-01, IDCT (Rebonuputemcel), Rexlemestrocel-L (MPC-06-ID), AMG0103 (NF-κB decoy oligonucleotide), BRTX-100, TG-C, Allogenic BM-MSCs, CELZ-201-DDT, and others.Discover what is the future of the degenerative disc disease treatment market @
More news about: DelveInsight Business Research, LLP
Jul 17, 2026, 00:30 ET Medtronic and Apollo Hospitals Announce Strategic Partnership to Establish State-of-the-Art Advanced ICU in Hyderabad
Innovation Center (MEIC). Key leaders from Apollo Hospitals, including Manpreet Singh, CEO, Apollo HealthAxis, Tejesvi Rao, CEO - Apollo Hospitals AP&TG, Dr. Sai Praveen Haranath, Chief Physician and Innovation Officer, and Dr. Rahul Khandelwal, VP, Partnerships and Client Solutioning, were also present
More news about: Medtronic
Jul 15, 2026, 08:00 ET Electra and Safran Reach Development and Production Agreement for TG600 Turbogenerator to Power EL9 Hybrid-Electric Aircraft
service expected in 2030. Under the agreement, the TG600 turbogenerator will become the heart of the EL9 Ultra Short's hybrid-electric propulsion system. The agreement follows a memorandum of understanding signed in 2023 and includes an initial order for 250 TG600 turbogenerators, allowing for production to
More news about: Electra.aero
Jun 30, 2026, 23:50 ET Der selektive PPARα-Modulator „K-808" (Pemafibrat) erhielt von der US-amerikanischen Food and Drug Administration (FDA) den Status „Breakthrough Therapy" für die Behandlung der primären biliären Cholangitis
Rezeptor-α-Modulator: SPPARMα), entwickelt von Kowa. Es verbessert den Fettstoffwechsel umfassend, beispielsweise durch Senkung der Triglyceridwerte (TG) im Blut, vor allem durch Regulierung der Expression von Zielgenen, die am Fett- und Glukosestoffwechsel in der Leber beteiligt sind. In Japan wurden
More news about: Kowa Company Ltd.
Jun 30, 2026, 13:11 ET Le modulateur sélectif du PPARα « K-808 » (pémafibrate) obtient la désignation « Breakthrough Therapy » par la U.S. Food and Drug Administration (FDA) pour le traitement de la cholangite biliaire primitive
peroxysomes : SPPARMα), mis au point par Kowa. Il améliore de manière globale le métabolisme lipidique, notamment en réduisant les taux de triglycérides (TG) sanguins, principalement grâce à la régulation de l'expression des gènes cibles impliqués dans le métabolisme des lipides et du glucose au niveau du
More news about: Kowa Company Ltd.
Jun 30, 2026, 10:00 ET Selective PPARα Modulator "K-808" (Pemafibrate) Granted "Breakthrough Therapy" Designation by the U.S. Food and Drug Administration (FDA) As a Treatment for Primary Biliary Cholangitis
Proliferator-Activated Receptor α Modulator: SPPARMα) developed by Kowa. It comprehensively improves lipid metabolism, such as by lowering blood triglyceride (TG) levels, primarily by regulating the expression of target genes involved in lipid and glucose metabolism in the liver. In Japan, "Parmodia Tablets" were
More news about: Kowa Company Ltd.
Jun 30, 2026, 10:00 ET L'attivatore selettivo del PPARα "K-808" (pemafibrato) ottiene la designazione di "Breakthrough Therapy" dalla Food and Drug Administration (FDA) statunitense per il trattamento della colangite biliare primitiva.
Proliferatori dei Perossisomi: SPPARMα) sviluppato da Kowa. Migliora in modo completo il metabolismo lipidico, ad esempio riducendo i livelli di trigliceridi (TG) nel sangue, principalmente regolando l'espressione dei geni bersaglio coinvolti nel metabolismo lipidico e glucidico nel fegato. In Giappone, le "compresse
More news about: Kowa Company Ltd.
Jun 30, 2026, 10:00 ET "K-808" recibió la designación de "terapia innovadora" de la FDA como tratamiento para la CBP
peroxisomas: SPPARMα) desarrollado por Kowa. Mejora de forma integral el metabolismo lipídico, por ejemplo, reduciendo los niveles de triglicéridos (TG) en sangre, principalmente mediante la regulación de la expresión de genes diana implicados en el metabolismo de los lípidos y la glucosa en el hígado.
More news about: Kowa Company Ltd.
Jun 23, 2026, 21:39 ET Luxshare Precision veröffentlicht Nachhaltigkeitsbericht 2025
Sorgfaltspflicht und zur Ausweitung der Anforderungen an eine verantwortungsvolle Beschaffung auf die gesamte Lieferkette. Alle in den Produkten enthaltenen 3TG-Mineralien stammten aus RMAP-konformen Schmelzwerken und Raffinerien und waren bis zum Herkunftsland rückverfolgbar, wodurch eine lückenlose Rückverfolgbarkeit
More news about: LUXSHARE-ICT
Jun 23, 2026, 21:36 ET Luxshare Precision publie son rapport 2025 sur le développement durable
ainsi qu'à étendre les exigences en matière d'approvisionnement responsable à l'ensemble de la chaîne logistique. L'ensemble des minerais de conflit (3TG) utilisés dans les produits provenaient de fonderies et d'affineries respectant le processus d'assurance des minerais responsables (RMAP), et leur traçabilité
More news about: LUXSHARE-ICT
Jun 23, 2026, 21:22 ET Luxshare Precision publica su informe de sostenibilidad de 2025
Guía de Debida Diligencia de la OCDE, y a extender los requisitos de abastecimiento responsable a toda la cadena de suministro. Todos los minerales 3TG utilizados en los productos se obtuvieron de fundiciones y refinerías que cumplen con la normativa RMAP y se pudo rastrear hasta el país de origen, lo
More news about: LUXSHARE-ICT